Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Journal of Human Hypertension|August 1, 1990
Resource savings from non-pharmacological control of hypertensionG M Ginsberg, R J Viskoper, S Oren, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|July 1, 1989
Cardiac, renal, and pulmonary toxicity of several mitomycin derivatives in ratsC L Bregman, R A Buroker, W T Bradner, et al.
Toxicologic Pathology|September 1, 1994
Etoposide- and BMY-40481-induced sensory neuropathy in miceC L Bregman, R A Buroker, R S Hirth, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|July 1, 1987
Single-dose and multiple-dose intravenous toxicity studies of BMY-25282 in ratsC L Bregman, C R Comereski, R A Buroker, et al.
The Netherlands Journal of Medicine|October 1, 1989
The antihypertensive effect of atenolol and bopindolol in the elderlyR J Viskoper, A Laszt, S Oren, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|February 7, 2001
BMS-189453, a novel retinoid receptor antagonist, is a potent testicular toxinG E Schulze, R J Clay, L E Mezza, et al.
Journal of Human Hypertension|December 1, 1993
Partial cost-benefit analysis of two different modes of nonpharmacological control of hypertension in the communityG M Ginsberg, J R Viskoper, Z Fuchs, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1990
Comparison of in vitro biological properties and mouse toxicities of three thymidine analogs active against human immunodeficiency virusM M Mansuri, M J Hitchcock, R A Buroker, et al.
Toxicologic Pathology|January 27, 2010
Incisor degeneration in rats induced by vascular endothelial growth factor/fibroblast growth factor receptor tyrosine kinase inhibitionAnthony M Fletcher, Carla L Bregman, Jochen Woicke, et al.
Pageof 3